Obesity associated hypertension: New insights into mechanism

Electrolyte and Blood Pressure

Volumn 11, Issue 2, 2013, Pages 46-52

  Kang, Young Sun ^a  

^a Korea University   (South Korea)

Author keywords

Hypertension; Insulin resistance; Microvascular dysfunction; Obesity; Renin angiotensin aldosterone system (RAAS)

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ADRENERGIC SYSTEM; AUTOCRINE EFFECT; BLOOD PRESSURE; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENERGY EXPENDITURE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPERTROPHY; INFLAMMATION; INTRACELLULAR SIGNALING; NONHUMAN; OBESITY; OXIDATIVE STRESS; PARACRINE SIGNALING; PHENOTYPE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

EID: 84905658394     PISSN: 17385997     EISSN: 20929935     Source Type: Journal    
DOI: 10.5049/EBP.2013.11.2.46     Document Type: Review

References (37)

1. Kramer H: Obesity and chronic kidney disease. Contrib Nephrol 151:1-18, 2006
2. Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al.: Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich) 15:14-33, 2013
3. Aghamohammadzadeh R, Heagerty AM: Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue. Ann Med 44 Suppl 1:S74-84, 2012
4. Westerbacka J, Vehkavaara S, Bergholm R, Wilkinson I, Cockcroft J, Yki-Jarvinen H: Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes 48:821-827, 1999 (Pubitemid 29153082)
5. Matsuzawa Y: The metabolic syndrome and adipocytokines. FEBS Lett 580:2917-2921, 2006
6. Ferrante AW, Jr.: Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 262:408-414, 2007
7. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993 (Pubitemid 23036092)
8. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668, 1996 (Pubitemid 26052915)
9. Schaffler A, Scholmerich J: Innate immunity and adipose tissue biology. Trends Immunol 31:228-235, 2010
10. Majdalawieh A, Ro HS: Regulation of Ikappa Balpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages. Mediators Inflamm 2010:823-821, 2010
11. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al.: CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15:914-920, 2009
12. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, et al.: Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15:930-939, 2009
13. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175-184, 2007 (Pubitemid 46048464)
14. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al.: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183-190, 2005 (Pubitemid 40321354)
15. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, et al.: Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59:1648-1656, 2010
16. Zeyda M, Gollinger K, Kriehuber E, Kiefer FW, Neuhofer A, Stulnig TM: Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression. Int J Obes (Lond) 34:1648-1694, 2010
17. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al.: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353:611-616, 1999 (Pubitemid 29087980)
18. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153, 2000
19. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995-1003, 2002 (Pubitemid 34286536)
20. Engeli S: Role of the renin-angiotensin-aldosterone system in the metabolic syndrome. Contrib Nephrol 151:122-134, 2006
21. Engeli S, Negrel R, Sharma AM: Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 35:1270-1277, 2000 (Pubitemid 30413663)
22. Campbell DJ, Habener JF: Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 121:1616-1626, 1987 (Pubitemid 18012763)
23. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, et al.: Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15:2727-2729, 2001
24. Hainault I, Nebout G, Turban S, Ardouin B, Ferre P, Quignard-Boulange A: Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am J Physiol Endocrinol Metab 282:E59-66, 2002 (Pubitemid 34654107)
25. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P: Increased adipose angiotensinogen gene expression in human obesity. Obes Res 8:337-341, 2000
26. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, et al.: Weight loss and the renin-angio tensin-aldosterone system. Hypertension 45:356-362, 2005 (Pubitemid 40315803)
27. Thatcher S, Yiannikouris F, Gupte M, Cassis L: The adipose renin-angiotensin system: role in cardiovascular disease. Mol Cell Endocrinol 302:111-117, 2009
28. Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, Ferre P, et al.: Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54:991-999, 2005 (Pubitemid 40446313)
29. Kouyama R, Suganami T, Nishida J, Tanaka M, Toyoda T, Kiso M, et al.: Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 146:3481-3489, 2005 (Pubitemid 41065022)
30. Santos SH, Fernandes LR, Mario EG, Ferreira AV, Porto LC, Alvarez-Leite JI, et al.: Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 57:340-347, 2008
31. Takahashi N, Li F, Hua K, Deng J, Wang CH, Bowers RR, et al.: Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab 6:506-512, 2007 (Pubitemid 350163052)
32. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, et al.: Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA 105:6531-6536, 2008 (Pubitemid 351754541)
33. Yvan-Charvet L, Quignard-Boulange A: Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 79:162-168, 2011
34. Lee MH, Song HK, Ko GJ, Kang YS, Han SY, Han KH, et al.: Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue. Kidney Int 74:890-900, 2008
35. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH: Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57:1511-1522, 2011
36. Aroor AR, Demarco VG, Jia G, Sun Z, Nistala R, Meininger GA, et al.: The Role of Tissue Renin-Angio-tensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness. Front Endocrinol (Lausanne) 4:161, 2013
37. De Boer MP, Meijer RI, Wijnstok NJ, Jonk AM, Houben AJ, Stehouwer CD, et al.: Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity- associated insulin resistance and hypertension. Microcirculation 19:5-18, 2012